Skip to main content

Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India, NDC 68180-723-20

Drug Recall

Official source record

Recall number
D-1406-2020
Event ID
85960
Classification
Class II
Status
Terminated
Recalling company
Lupin Pharmaceuticals Inc.
Reason for recall
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.
Report date
July 29, 2020
Recall initiation date
July 2, 2020
Termination date
June 30, 2021
Distribution pattern
U.S.A. Nationwide

Drug product identifiers

Manufacturer
Lupin Pharmaceuticals, Inc.
Brand name
CEFDINIR
Generic name
CEFDINIR
Substance name
CEFDINIR
Product NDCs
68180-722; 68180-723
Package NDCs
68180-722-04; 68180-722-05; 68180-722-10; 68180-722-20; 68180-723-04; 68180-723-05; 68180-723-10; 68180-723-20
Route
ORAL

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to the FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.